Premium
Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service
Author(s) -
Finning K.M.,
Martin P.G.,
Soothill P.W.,
Avent N.D.
Publication year - 2002
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.2002.00165.x
Subject(s) - genotyping , fetus , cell free fetal dna , pregnancy , obstetrics , typing , testis determining factor , prenatal diagnosis , medicine , biology , y chromosome , genotype , genetics , gene
BACKGROUND: Invasive procedures to obtain fetal DNA for prenatal blood grouping present a risk to the fetus. During pregnancy, cell‐free fetal DNA is present in maternal blood. The detection ofRHDsequences in maternal plasma has been used to predict fetal D status, based on the assumption thatRHD is absent in D– genomes. STUDY DESIGN AND METHODS: Real‐time PCR assays were designed to distinguishRHDfromRHDΨ (possessed by the majority of D– black Africans). Plasma‐derived DNA from 137 D– women was subjected to real‐time PCR to detect fetalRHDand Y chromosome‐associatedSRYsequences. The accuracy ofRHDgenotyping from maternal plasma was investigated by comparing results with those obtained by conventionalRHD genotyping from fetal tissue or serologic tests on the infant's RBCs. The quantity of fetal DNA in maternal plasma was investigated in 94 pregnancies. RESULTS : Fetal D status was predicted with 100‐ percent accuracy from maternal plasma. The number of copies of fetal DNA in maternal plasma was found to increase with gestation. CONCLUSION: Combination of the sensitivity of real‐time PCR with an improvedRHDtyping assay to distinguishRHDfromRHDΨ enables highly accurate prediction of fetal D status from maternal plasma. This has resulted in the implementation of a clinical noninvasive fetalRHD genotyping service.